Leaflet ROXIHEFA 150mg film-coated tablets
Indicated for: bacterial infections
Route of administration: oral
Substance: roxithromycin (macrolide antibiotic)
ATC: J01FA06 (Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins)
Dose adjustment may be needed in kidney disease.
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Seek medical advice if severe or persistent diarrhea occurs.
This medicine may have important interactions with other medicines.
This medicine may increase the risk of heart rhythm disturbances.
Roxithromycin is a macrolide antibiotic used in the treatment of bacterial infections of the respiratory tract, skin, and soft tissues. It works by inhibiting bacterial protein synthesis, thereby blocking the growth and multiplication of susceptible bacteria.
Roxithromycin is administered orally, usually in tablet form, and is effective against a wide range of bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae. It is commonly used to treat bronchitis, pharyngitis, tonsillitis, and skin infections.
Common side effects include nausea, diarrhea, abdominal pain, and headache. In rare cases, severe allergic reactions or liver disorders may occur. It is important to take it as directed by a physician to prevent the development of bacterial resistance.
Roxithromycin is an effective and well-tolerated option for the treatment of bacterial infections, helping patients recover quickly.
General data about ROXIHEFA 150mg
- Substance: roxithromycin
- Date of latest medicines list: 01-07-2013
- Product code: W42345001
- Concentration: 150mg
- Pharmaceutical form: film-coated tablets
- Quantity: 10
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for roxithromycin
Concentrations available for roxithromycin
- 150mg
- 300mg
- 50mg